Source:http://linkedlifedata.com/resource/pubmed/id/17400889
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2007-6-20
|
pubmed:abstractText |
We have demonstrated that caspase-1-deficient (caspase-1(-/-)) mice are functionally and histologically protected against cisplatin-induced acute renal failure (ARF). Caspase-1 exerts proinflammatory effects via the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil recruitment. We sought to determine the role of the cytokines IL-1beta, IL-18, and IL-6 and neutrophil recruitment in cisplatin-induced ARF. We first examined IL-1beta; renal IL-1beta increased nearly 2-fold in cisplatin-induced ARF and was reduced in the caspase-1(-/-) mice. However, inhibition with IL-1 receptor antagonist (IL-1Ra) did not attenuate cisplatin-induced ARF. Renal IL-18 increased 2.5-fold; however, methods to inhibit IL-18 using IL-18 antiserum and transgenic mice that overproduce IL-18-binding protein (a natural inhibitor of IL-18) did not protect. Renal IL-6 increased 3-fold; however, IL-6-deficient (IL-6(-/-)) mice still developed cisplatin-induced ARF. We next examined neutrophils; blood neutrophils increased dramatically after cisplatin injection; however, prevention of peripheral neutrophilia and renal neutrophil infiltration with the neutrophil-depleting antibody RB6-8C5 did not protect against cisplatin-induced ARF. In summary, our data demonstrated that cisplatin-induced ARF is associated with increases in the cytokines IL-1beta, IL-18, and IL-6 and neutrophil infiltration in the kidney. However, inhibition of IL-1beta, IL-18, and IL-6 or neutrophil infiltration in the kidney is not sufficient to prevent cisplatin-induced ARF.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 1,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-18,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1beta,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0022-3565
|
pubmed:author |
pubmed-author:DinarelloCharles ACA,
pubmed-author:EdelsteinCharles LCL,
pubmed-author:FaubelSarahS,
pubmed-author:HokeThomas STS,
pubmed-author:KleinChristina LCL,
pubmed-author:LewisEli CEC,
pubmed-author:LjubanovicDanicaD,
pubmed-author:LuLawrenceL,
pubmed-author:OhDong-JinDJ,
pubmed-author:ReznikovLeonidL,
pubmed-author:SomersetHilaryH
|
pubmed:issnType |
Print
|
pubmed:volume |
322
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8-15
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17400889-Acute Kidney Injury,
pubmed-meshheading:17400889-Animals,
pubmed-meshheading:17400889-Antineoplastic Agents,
pubmed-meshheading:17400889-Caspase 1,
pubmed-meshheading:17400889-Cisplatin,
pubmed-meshheading:17400889-Interleukin-18,
pubmed-meshheading:17400889-Interleukin-1beta,
pubmed-meshheading:17400889-Interleukin-6,
pubmed-meshheading:17400889-Kidney,
pubmed-meshheading:17400889-Male,
pubmed-meshheading:17400889-Mice,
pubmed-meshheading:17400889-Mice, Inbred C57BL,
pubmed-meshheading:17400889-Neutrophil Infiltration,
pubmed-meshheading:17400889-Neutrophils
|
pubmed:year |
2007
|
pubmed:articleTitle |
Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney.
|
pubmed:affiliation |
Division of Renal Diseases and Hypertension, University of Colorado School of Medicine, Box C281, 4200 E. 9th Ave, Denver, CO 80262, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|